Monday, July 22, 2013 1:33:15 PM
Nooo! But I figure Patrick Cox has a schedule of catalysts and I was trying to guesstimate what that schedule looked like. I have a few thousand shares and holding. I am not a trader, although in the near future I would like to become one.
I was also trying to draw attention to the NNVC-RedChip video because embedded in them is good information. Anyone can draw their own conclusions from them but I suspect they will not be far from mine. The information is there!
I condensed information that I sent on e-mail to friends and family, with the usual disclaimer of course. That is what I posted this morning.
I always keep reminding myself NNVC leadership is frugal. That is why the CEO, a physician/epidemiologist (not a sales/marketing specialist), is taking the initiative to do the conferences, the interviews, etc.. He does a good job.
I also have a brother and nephew; they were both bitten by the "Aedes Aegypti" mosquitoes in Puerto Rico and ended up in the hospital with Dengue and hemorrhagic fever. So when the good doc says "you feel like you want to die" I know first hand because that is what my brother told me it was like.
I read with great interest everyone's posts, some of them very funny,..that one on Kate giving birth,...funny. I hope NNVC goes forward to fulfill its promise and realize its great potential, soon.
GO NNVC!!!!
I was also trying to draw attention to the NNVC-RedChip video because embedded in them is good information. Anyone can draw their own conclusions from them but I suspect they will not be far from mine. The information is there!
I condensed information that I sent on e-mail to friends and family, with the usual disclaimer of course. That is what I posted this morning.
I always keep reminding myself NNVC leadership is frugal. That is why the CEO, a physician/epidemiologist (not a sales/marketing specialist), is taking the initiative to do the conferences, the interviews, etc.. He does a good job.
I also have a brother and nephew; they were both bitten by the "Aedes Aegypti" mosquitoes in Puerto Rico and ended up in the hospital with Dengue and hemorrhagic fever. So when the good doc says "you feel like you want to die" I know first hand because that is what my brother told me it was like.
I read with great interest everyone's posts, some of them very funny,..that one on Kate giving birth,...funny. I hope NNVC goes forward to fulfill its promise and realize its great potential, soon.
GO NNVC!!!!
Recent NNVC News
- In the Ebola Emergency, NV-387 is Ready to be Shipped to DRC, and It Compares Favorably as a Treatment for Ebola Versus Possible Options, Says NanoViricides • ACCESS Newswire • 05/26/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2026 10:01:46 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 08:30:33 PM
- NanoViricides Announces Closing of ~$2 Million Registered Direct Offering • ACCESS Newswire • 05/19/2026 03:55:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/18/2026 12:45:22 PM
- Ebola Global Health Emergency Needs a Broad-Spectrum Drug - NV-387 is a Strong Potential Candidate, Says NanoViricides • ACCESS Newswire • 05/18/2026 12:30:00 PM
- NanoViricides Announces Pricing of ~$2 Million Registered Direct Offering • ACCESS Newswire • 05/15/2026 12:35:00 PM
- NanoViricides, Inc. Has Filed its Quarterly Report - NV-387 Advancing for Phase II • ACCESS Newswire • 05/15/2026 12:00:00 PM
- Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides • ACCESS Newswire • 05/11/2026 12:30:00 PM
- NanoViricides, Inc. Announces Participation in the D. Boral Capital Global Conference • Newsfile • 05/06/2026 07:37:00 PM
- NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA • ACCESS Newswire • 05/04/2026 12:30:00 PM
- Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides • ACCESS Newswire • 04/21/2026 12:30:00 PM
- Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides • ACCESS Newswire • 04/07/2026 12:30:00 PM
- Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides • ACCESS Newswire • 04/01/2026 12:30:00 PM
- NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete • ACCESS Newswire • 03/11/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:30:47 PM
- MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/12/2026 01:30:00 PM
- Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/10/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 09:30:18 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/16/2025 09:30:05 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/15/2025 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:30:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:32:10 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 07:54:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 04:29:54 PM
